Pharmaceuticals

Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020

  • ALL132567
  • 0 Pages
  • September 2014
  • Pharmaceuticals

Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. Initial symptoms of this disease include sore throat, headaches, fever and muscles pain. It causes hemorrhagic fever that leads to internal or external bleeding. EVD is widely prevalent in Central and Western Africa, and near tropical rainforests. Due to high mortality rate and unavailability of effective treatments, the pharmaceutical companies have big opportunities to explore. Tekmira Pharmaceuticals, BioCryst Pharmaceutical Inc., Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical are some of the leading companies focusing on research activities to develop efficacious medicine for EVD. Additionally, the governments in the developed countries have also taken formidable steps to support the research activities for the development of EVD therapeutics by providing funding and floating favorable policies. As an example, Tekmira Pharmaceuticals has received fast-track designation from U.S. food and drug administration for their anti-ebola therapeutic TKM-ebola. In 2012, Sarepta Therapeutics had also received fast track designation for AVI-7537, a lead drug candidate for EVD. Both these companies are developing their anti-ebola products under the contract of the U.S. department of defense (DoD).

Ebola therapeutics and vaccines market is segmented on the basis of geography into North America, Europe, Asia-pacific and LAMEA. EVD is rampant in LAMEA regions, specifically in African countries. This is a positive sign for pharmaceutical companies, portraying a highly lucrative market in the future. Earlier, US government did not have any regulations for EVD therapeutics due to negligible incidences of this disease in developed economies. However, preference of African people to migrate to developed economies rather than developing economies has cautioned the governments in the developed economies, leading to formulate regulations in order to curb the spread of this disease. 

Global Potential Analysis of Ebola drug and Vaccines Market

KEY BENEFITS

This report offers the following benefits in particular:

  • To track commercial trends, major clinical trials and their status are pursued of closely
  • The report sheds light on the key events held in past years concerning the development of ebola viral disease therapeutics
  • Pin-point analysis of geographic segments helps to identify opportunities for growth within the ebola therapeutics and vaccines market
  • Porter’s Five Forces analysis examines the competitive structure of the ebola therapeutics and vaccines market and would assist market strategists in their respective decision making process
  • In-depth coverage of the ebola therapeutics and vaccines market including drivers, restraints and opportunities would help professionals to better understand market behavior
  • Detailed study of the strategies of key leaders, partnerships and acquisitions in the ebola therapeutics and vaccines market would be informative for professionals in corporate sector 

KEY MARKET SEGMENTS

Ebola therapeutics and vaccines market is segmented on the basis of geography. 

  • LAMEA
  • North America
  • Europe
  • Asia-Pacific
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Large Volume Parenteral (LPV) Market (Treatment Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Fluid Management & Visualization Systems Market (Product Type, Application, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

A fluid Management and Visualization system is used to balance body fluid in order to prevent complications associated with an undesired fluid level. It is also used for the early ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Pharmacy Automation Systems Market (Application, End-User and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Pharmacy automation system involves the automation of workflow tasks in the fields of pharmacy or healthcare, such as object counting, prescription management, compound preparation, dispensing, medication packaging and inventory management. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Paclitaxel Injection Market (Treatment of Cancer and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Paclitaxel belongs to the group of medications known as antineoplastics and is used in the treatment of cancers. It works by inhibiting the growth of cancer cells and is used ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>